This Government Contract opportunity from Hawaii was posted on August 22, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Medication-Assisted Treatment (MAT/MOUD) Services

Closed

State & Local

Submission Closed09/05/2025, 12:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621410

New

DIBBS

CUVETTE, TEST, PROTIME

Solicitation # SPE2DS-27-T-1011

Solicitation SPE2DS-27-T-1011, issued by DLA Troop Support Medical Supply Chain MD Surg FSF, is a request for quotations for Protime testing cuvettes (NSN 6550-01-519-3883) used with Hemochron Signature Jr devices for prothrombin time tests. The requirement is for one package containing 45 cuvettes, with a delivery timeline of 84 days after order. The items must be delivered FOB Destination to the USA Medical Materiel Center in Korea. The contract imposes strict quality and shelf-life requirements, specifying a non-extendable shelf life of three months, with a mandate that no more than 15 days elapse between the date of manufacture and delivery to the government. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and MMS1C for shelf-life labels. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include electronic invoicing via Wide Area WorkFlow and compliance with the Buy American Act and Berry Amendment for domestic materials. The solicitation is open to small businesses under NAICS 621410 and may be subject to automated award. Offerors must submit quotes via DIBBS and are prohibited from using additive manufacturing processes unless specifically authorized.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DS-27-T-1013

Solicitation SPE2DS-27-T-1013 is a small business set-aside request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of coagulation control solution (NSN 6550-01-519-5569). This abnormal level control solution is used for aPTT coagulation testing and each package must contain 15 abnormal level vials and 4 protective sleeves. The item is regulated by the FDA and requires strict temperature control, necessitating refrigeration between 2 and 8 degrees Celsius (36 to 46 degrees Fahrenheit). The contract mandates that the product be delivered within 84 days after order (ADO) to the USA Med Materiel Center in Korea, with terms set as FOB Destination. Critical quality requirements include a shelf-life restriction where no more than one month may have elapsed from the date of manufacture to the date of government delivery. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1. The procurement is governed by various FAR and DFARS clauses, including those regarding the Buy American Act, cybersecurity reporting, and the use of the Wide Area WorkFlow system for electronic invoicing.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DS-27-T-1012

Solicitation SPE2DS-27-T-1012 is a Request for Quotations issued by the Department of Defense Medical Supply Chain for the procurement of one package of Normal Level Plasma Control for APTT tests, identified by NSN 6550-01-519-3928. The product is designed for use with Hemochron Jr. APTT cuvettes and coagulation analyzer NSN 6630-01-519-3589. Each package must contain 15 vials and 4 protective sleeves. This is an FDA-regulated device with a strict non-extendable shelf life of 3 months. A critical delivery requirement stipulates that no more than 15 days shall elapse between the date of manufacture and the date of delivery to the government. The item requires continuous refrigeration between 2 and 8 degrees Celsius (36 to 46 degrees Fahrenheit). The contract specifies delivery within 84 days, with FOB Destination terms for delivery to locations in the United States and South Korea. Packaging must adhere to MIL-STD-2073-1E and Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various DFARS and FAR clauses, including the Buy American Act and cybersecurity reporting standards under DFARS 252.204-7012. Quotations must be submitted via the DLA Internet Bid Board System (DIBBS) by November 2, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL SET, BLOOD CHEM

Solicitation # SPE2DS-27-T-0905

Solicitation SPE2DS-27-T-0905, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of two packages of blood chemistry control sets (NSN 6550-01-557-1581). These liquid general chemistry and lipid control combo kits are designed for use with Piccolo Express analyzers and include both high and low chemistry controls in 1 ml vials. The material is subject to strict temperature requirements and must be shipped and received frozen at -18 degrees Celsius (0 degrees Fahrenheit). Each package consists of 12 total vials, with six high and six low controls. The contract specifies a 12-month non-extendable shelf life, requiring that no more than one month elapses between the date of manufacture and the delivery date to the government. Delivery is required within 20 days after order (ADO) to the USS John P Murtha LPD 26. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1. The procurement is not a small business set-aside and falls under NAICS code 621410. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, hazardous materials, and the Buy American program.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, DENGUE ANTIGE

Solicitation # SPE2DS-27-T-0933

Solicitation SPE2DS-27-T-0933 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain for the procurement of two Dengue Antigen Assay test kits (NSN 6550-01-602-7751). Each kit is supplied in a white plastic box and contains materials for fifty tests, including 50 assay dipsticks, two 44 ml bottles of grinding solution, 50 Eppendorf grinding tubes, a vial of 200 metal BBs, 50 capped sterile BD culture tubes, five ten-hole tube stands, two grinders, five pestles, and product instructions. Delivery is required within 20 days after receipt of order, with the destination and acceptance point located at Fort Campbell, Kentucky. The contractor must adhere to strict quality and shelf-life requirements, ensuring items have a 24-month shelf life and are delivered within three months of the manufacture date. Packaging must comply with commercial standards, specifically ASTM D3951 and MIL-STD-129 for marking and labeling, while palletization must follow RP001. Invoicing and receiving reports are to be processed electronically via the Wide Area WorkFlow system. This procurement is not a small business set-aside and includes various federal regulations regarding cybersecurity, the Buy American Act, and prohibitions on covered telecommunications equipment.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DS-27-T-0919

Solicitation SPE2DS-27-T-0919 is issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of coagulation control vials, identified by NSN 6550-01-533-2811. Each package must contain 15 normal level vials and 4 protective sleeves. This FDA-regulated medical device requires strict temperature control, necessitating refrigeration between 2 and 8 degrees Celsius. The item has a non-extendable shelf life of 18 months. Delivery is required within 84 days after receipt of order, with the destination for inspection and acceptance located at the point of delivery in South Korea. The contractor must adhere to commercial packaging standards, utilizing sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and special packaging instructions MPFWN00001. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system. This is not a small business set-aside, and the acquisition falls under NAICS code 621410. Key regulatory compliance includes the Buy American Act, DFARS requirements for covered defense telecommunications, and the Hazard Communication Standard for any hazardous material labeling.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

FECAL SPECIMEN COLLECT

Solicitation # SPE2DS-27-T-0911

Solicitation SPE2DS-27-T-0911 is a federal procurement for the supply of Fecal Specimen Collection and Transportation Kits (NSN 6550010829975) intended for parasitological examination. The requirement is for one package consisting of 10 units, with a delivery timeline of 84 days after order. The items are classified as Type I (Code H) with a non-extendable shelf life of 12 months. Delivery is designated as FOB Destination to the USA Medical Materiel Center in Korea. The contract mandates strict adherence to Medical Marking Standard No. 1 and MIL-STD-2073-1E for packaging. If the items are classified as hazardous, the contractor must provide a current Material Safety Data Sheet (MSDS) to DSCP and include a copy with every shipment. The procurement is not a small business set-aside and falls under NAICS code 621410. Key administrative requirements include electronic invoicing via the Wide Area WorkFlow (WAWF) system and compliance with various FAR and DFARS clauses regarding hazardous materials, cybersecurity, and the prohibition of certain toxic substances. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Targeted Outreach for Pregnant Women Act (TOPWA)

Solicitation # 26-003

The Targeted Outreach for Pregnant Women Act (TOPWA) solicitation, issued by the Florida Department of Health Bureau of Communicable Diseases, HIV/AIDS Section, seeks applications for the 2027 fiscal year to reduce disparities in perinatal HIV prevention. The program focuses on early identification, engagement, and linkage to care for pregnant women facing socioeconomic challenges or limited healthcare access. Key deliverables include implementing outreach plans, providing direct testing for HIV, HBV, and HCV, linking newly diagnosed patients to medical care within 30 calendar days, and increasing access to affordable medications. The anticipated contract period is from January 1, 2027, through December 31, 2027, with the potential for a total duration of three years subject to annual funding. The Department has allotted 1,000,000 dollars annually for the entire program, with individual applicants eligible to request between 125,000 and 175,000 dollars per year. A required 25 percent match of the requested funding is mandatory, and applicants must demonstrate the capacity to provide testing services directly. Applications are evaluated on a 120-point scale, with the highest weights assigned to the Program Proposal, Statement of Need, Organizational Capacity, and Collaborations. Submissions must be uploaded electronically by September 30, 2026, and must include a detailed budget, work plan, and various certifications, including an Executive Compensation Disclosure and Attestation Survey.

POSTED

DEADLINE

Title X Family Planning Subrecipient Opportunities

Solicitation # 26RFI19941

The South Dakota Department of Health is issuing an exploratory Request for Information, solicitation number 26RFI19941, to identify organizations interested in serving as subrecipients under the Title X Family Planning Program. The primary objective is to assess statewide capacity, service availability, and potential partnerships to provide comprehensive, affordable, and confidential reproductive health services. These services include contraceptive supplies, pregnancy testing, STI testing and treatment, HIV screening, preconception planning, basic infertility services, and community outreach. This RFI is strictly informational and does not constitute a commitment by the state to award funding or enter into a contract. Interested organizations must submit their responses in PDF format by 5:00 PM Mountain Standard Time on Friday, October 30, 2026. Submissions should be sent via email to Nikki Krier or by mail to the Rapid City office, and must not be submitted through ESM Sourcing. Responses should provide a concise organizational overview, details on service capacity and geographic reach, operational readiness regarding staffing and electronic health records, and the organization's level of interest in becoming a subrecipient. Potential partners must demonstrate the ability to comply with Title X program requirements, specifically concerning data reporting and patient confidentiality.

South Dakota State Government

POSTED

DEADLINE

Long-Term Residential Nursing Care ServicesThe contract involves the provision of continuous, round-the-clock skilled nursing care tailored specifically for veterans in a long-term residential care environment. It encompasses key services such as medication management, monitoring of chronic diseases, and assistance with daily living activities. These services are designed to ensure comprehensive health support and improve the quality of life for veterans requiring extended care. Issued by the Department of Veterans Affairs under the NAICS code 621410, this subcontract focuses on specialized healthcare delivery within a residential nursing facility setting. Although specific location and contact details are not provided, the contract's aim is to facilitate expert nursing services that address both medical and personal care needs of veterans, reflecting a commitment to maintaining their well-being over an extended period.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Solicitation # NSF 26-510

Program solicitation NSF 26-510, issued by the National Science Foundation on May 22, 2026, seeks proposals for the Small Business Innovation Research and Small Business Technology Transfer Phase I, Phase II, and Fast-Track programs. Managed by the Directorate for Technology, Innovation and Partnerships, this initiative focuses on developing deep technologies to enhance U.S. competitiveness and security. The solicitation is a total small business set-aside for firms with fewer than 500 employees and replaces previous solicitations NSF 24-579, 24-580, and 24-582. Applicants must comply with the Proposal and Award Policies and Procedures Guide and updated research security policies. The anticipated total funding amount for this program is 210 million dollars. Funding levels vary by award type, with Phase I grants up to 305,000 dollars, Phase II cooperative agreements up to 1,250,000 dollars, and Fast-Track awards up to 1,555,555 dollars. Additionally, active Phase II awardees may apply for Phase IIB supplements between 50,000 and 500,000 dollars or Commercial Partnerships supplements up to 20 percent of their Phase II award. Strategic Breakthrough proposals may request up to 30 million dollars. Full proposal deadlines are scheduled periodically between July 27, 2026, and July 2027.

National Science Foundation

POSTED

DEADLINE

Outpatient and Inpatient Detoxification ServicesThis contract involves providing medically supervised detoxification services, including both outpatient and residential care, for individuals struggling with substance dependence. The services incorporate medication-assisted treatment to support recovery and ensure medically safe withdrawal. The contract is a subcontract under the NAICS code 621410, which pertains to offices of physicians and related health services. The contract was posted on May 20, 2026, and is managed by the US Probation office in Sacramento, California, operating under the Judicial Branch. The place of performance is specified as Chico, indicating where the service delivery will primarily occur. The contract emphasizes comprehensive detox support within a structured medical setting to facilitate effective treatment for individuals overseeing their substance dependence issues.

US Probation Sacramento Ca E

POSTED

5 months ago

DEADLINE

N/A

AI Contract Overview

The Hawaii Health Systems Corporation is seeking a subcontractor to provide Medication-Assisted Treatment services for individuals with substance use disorders. The scope of work focuses on comprehensive medication management, specifically the prescribing and monitoring of medications for opioid use disorder, such as buprenorphine and naltrexone, alongside necessary adherence support. This opportunity is categorized under NAICS code 621410. Interested parties must submit their responses by the deadline of September 5, 2025. Further details regarding the solicitation can be accessed through the Hawaii state procurement portal.

General Info

Agency

Hawaii Health Systems Corporation

NAICS

621410 - Family Planning Centers

Place of Performance

HI, USA

Set-Aside

NONE

Documents

This scope was carved out of AMHD 420-4-26.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Integrated Behavioral Health Services at the Central Receiving Division

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedAug 22

subcontract

Response DeadlineSep 5

Deadline has passed

Submission Closed

09/05/2025, 12:00:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyHawaii Health Systems Corporation

ContactsNo contacts available

OfficeN/A

Organization / AgencyHawaii Health Systems Corporation

Office AddressN/A

ContactsNo contact information available

Full Description

Deliver medication management for substance use disorders, including prescribing and monitoring of MOUD such as buprenorphine and naltrexone, with adherence support.